Ultragenyx Pharmaceutical Files 8-K on Financials
Ticker: RARE · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1515673
| Field | Detail |
|---|---|
| Company | Ultragenyx Pharmaceutical Inc. (RARE) |
| Form Type | 8-K |
| Filed Date | Aug 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: UGNX
TL;DR
UGNX filed an 8-K on 8/5/25 detailing financial results. Check it out.
AI Summary
Ultragenyx Pharmaceutical Inc. filed an 8-K on August 5, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 60 Leveroni Court, Novato, California.
Why It Matters
This 8-K filing provides an update on Ultragenyx Pharmaceutical's financial performance and condition, which is crucial information for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial results and does not appear to contain any significant new risks or negative developments.
Key Players & Entities
- Ultragenyx Pharmaceutical Inc. (company) — Registrant
- August 05, 2025 (date) — Date of earliest event reported
- 60 Leveroni Court, Novato, California 94949 (location) — Principal Executive Offices
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on August 5, 2025.
What is the principal business address of Ultragenyx Pharmaceutical Inc.?
The principal executive offices are located at 60 Leveroni Court, Novato, California 94949.
What is the Commission File Number for Ultragenyx Pharmaceutical Inc.?
The Commission File Number is 001-36276.
What is the IRS Employer Identification Number (EIN) for Ultragenyx Pharmaceutical Inc.?
The IRS Employer Identification Number is 27-2546083.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Ultragenyx Pharmaceutical Inc. (RARE).